STBT5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(33 intermediate revisions by 4 users not shown)
Line 226: Line 226:
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|Minimal genetic content added
|-
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
Line 248: Line 248:
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|10/16/2025
|
|Katie Schieffer
|
|10/16/2025
|
|No genetic association
|-
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|[[STBT5:Elastofibroma|Elastofibroma]]
Line 267: Line 267:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
Line 280: Line 289:
|-
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|9/22/2025
|Katie Schieffer
|9/22/2025
|No genetic association
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|Disease
|Disease
|
|
Line 290: Line 310:
|
|
|-
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|Disease
|
|
Line 301: Line 332:
|
|
|-
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|Disease
|
|
Line 312: Line 343:
|
|
|-
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|Disease
|Disease
|
|
Line 323: Line 354:
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|Disease
|
|
Line 334: Line 365:
|
|
|-
|-
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|Disease
|Disease
|
|
Line 345: Line 376:
|
|
|-
|-
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|Disease
|Disease
|
|
Line 356: Line 407:
|
|
|-
|-
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|Disease
|Disease
|
|
Line 367: Line 418:
|
|
|-
|-
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|No genetic association
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|Disease
|Disease
|
|
Line 378: Line 440:
|
|
|-
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|Disease
|Disease
|
|
Line 389: Line 451:
|
|
|-
|-
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Kati
e Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|Minimal genetic content added
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|Disease
|
|
Line 400: Line 474:
|
|
|-
|-
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|Disease
|
|
Line 411: Line 485:
|
|
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|Disease
|Disease
|
|
Line 422: Line 496:
|
|
|-
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|Disease
|
|
Line 433: Line 507:
|
|
|-
|-
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Yiting Li (trainee);
Shashirekha Shetty (mentor)
|9/24/2025
|12/24/2025
|COMPLETE
|12/18/2025
|Katie Schieffer
|12/18/2025
|
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|Disease
|
|
Line 444: Line 539:
|
|
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|Disease
|Disease
|
|
Line 455: Line 561:
|
|
|-
|-
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|
|Disease
|Katie Schieffer
|4/21/2025
|10/1/2025
|COMPLETE
|9/18/2025
|Katie Schieffer
|9/18/2025
|
|
|-
|-
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|Disease
|Disease
|
|
Line 477: Line 595:
|
|
|-
|-
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|Disease
|
|
Line 488: Line 606:
|
|
|-
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|Disease
|Disease
|Shashi Shetty and Reba Daniel (resident)
|
|2/21/2024
|
|PENDING
|
|Katherine Geiersbach
|
|Template added 2/21/2024
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|
|
|
|
|
Line 510: Line 617:
|
|
|-
|-
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|Disease
|Disease
|
|
Line 521: Line 628:
|
|
|-
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|Disease
|Disease
|
|
Line 532: Line 648:
|
|
|-
|-
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 543: Line 659:
|
|
|-
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|Disease
|Katie Schieffer
|Katie Schieffer
|4/21/2025
|9/21/2025
|
|12/21/2025
|PENDING
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|No genetic association
|-
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Disease
|
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/10/2025
|Katie Schieffer
|11/10/2025
|No genetic association
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|
|
|
|
|
Line 565: Line 714:
|
|
|-
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|Disease
|
|
Line 576: Line 736:
|
|
|-
|-
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|Disease
|
|
Line 587: Line 747:
|
|
|-
|-
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 598: Line 767:
|
|
|-
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|Disease
|
|
Line 609: Line 778:
|
|
|-
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|Disease
|
|
Line 620: Line 811:
|
|
|-
|-
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 631: Line 822:
|
|
|-
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|Disease
|Disease
|
|
Line 642: Line 833:
|
|
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|Disease
|
|
Line 653: Line 844:
|
|
|-
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|Disease
|
|
Line 664: Line 855:
|
|
|-
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|[[STBT5:Glomus_tumour|Glomus tumour]]
|Disease
|Disease
|
|
Line 675: Line 866:
|
|
|-
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|Disease
|
|
Line 686: Line 886:
|
|
|-
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|Disease
|
|
Line 697: Line 897:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|[[STBT5:Leiomyoma|Leiomyoma]]
|Disease
|Disease
|
|
Line 708: Line 908:
|
|
|-
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|Disease
|
|
Line 719: Line 930:
|
|
|-
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|Disease
|
|
Line 730: Line 941:
|
|
|-
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|Disease
|Disease
|
|
Line 741: Line 952:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 752: Line 963:
|
|
|-
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 763: Line 974:
|
|
|-
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 774: Line 985:
|
|
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 785: Line 1,005:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|Disease
|
|
Line 796: Line 1,016:
|
|
|-
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|Disease
|
|
Line 807: Line 1,027:
|
|
|-
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|Disease
|
|
Line 818: Line 1,038:
|
|
|-
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|Disease
|
|
Line 829: Line 1,049:
|
|
|-
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 840: Line 1,060:
|
|
|-
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|[[STBT5:Neurofibroma|Neurofibroma]]
|Disease
|Disease
|
|
Line 851: Line 1,071:
|
|
|-
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|[[STBT5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|
Line 862: Line 1,082:
|
|
|-
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|Disease
|
|
Line 873: Line 1,093:
|
|
|-
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/11/2025
|
|Katie Schieffer
|
|12/11/2025
|
|No genetic association
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Consider linking to CNS tumor book
|
|
|
|
|-
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|Disease
|
|
Line 906: Line 1,146:
|
|
|-
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|Disease
|
|
Line 917: Line 1,157:
|
|
|-
|-
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|Disease
|
|
Line 928: Line 1,168:
|
|
|-
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 939: Line 1,179:
|
|
|-
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|Disease
|
|
Line 950: Line 1,190:
|
|
|-
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|Disease
|
|
Line 959: Line 1,210:
|
|
|
|
|
|
|-
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|Disease
|
|
Line 972: Line 1,223:
|
|
|-
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 983: Line 1,243:
|
|
|-
|-
|[[STBT5:Schwannoma|Schwannoma]]
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|Disease
|
|
Line 994: Line 1,254:
|
|
|-
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|Disease
|
|
Line 1,005: Line 1,265:
|
|
|-
|-
|[[STBT5:Perineurioma|Perineurioma]]
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|9/11/2025
|12/11/2025
|COMPLETE
|12/29/2026
|Katie Schieffer
|1/7/2026
|
|
|
|-
|
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
Line 1,016: Line 1,289:
|
|
|-
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|Disease
|
|
Line 1,027: Line 1,300:
|
|
|-
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 1,049: Line 1,322:
|
|
|-
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|Disease
|
|
Line 1,060: Line 1,333:
|
|
|-
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|Maxine Sutcliffe, PhD
|10/13/2025
|12/31/2025
|COMPLETE
|12/24/2025
|Katie Schieffer
|12/24/2025
|
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|Disease
|
|
Line 1,071: Line 1,355:
|
|
|-
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,082: Line 1,375:
|
|
|-
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|Disease
|Maxine Sutcliffe, PhD
|1/12/2026
|4/12/2026
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|
|
|-
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 1,104: Line 1,397:
|
|
|-
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|[[STBT5:PEComa|PEComa]]
|Disease
|Disease
|
|
Line 1,115: Line 1,408:
|
|
|-
|-
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|Disease
|
|
Line 1,126: Line 1,419:
|
|
|-
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|Disease
|
|
Line 1,137: Line 1,430:
|
|
|-
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|
|
|
|
|
----
|
|
----
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Sadeem Qdaisat (trainee); Eric McGinnis (mentor)
|10/1/2023
|12/9/2025
|PENDING
|
|
|Katie Schieffer
|
|
|
|
|-
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|Disease
|
|
Line 1,170: Line 1,473:
|
|
|-
|-
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Disease
|
|
Line 1,181: Line 1,484:
|
|
|-
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|Disease
|
|
Line 1,192: Line 1,495:
|
|
|-
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|-
|Disease
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|
----
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|
|
|
|-
|
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
Line 1,214: Line 1,558:
|
|
|-
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|Disease
|James Solomon, MD, PhD
|Katie Schieffer
|2/20/2022
|9/21/2025
|12/21/2025
|PENDING
|
|
|PENDING
|
|
|Alanna Church
|
|
|
|
|-
|-
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|
|
|-
|
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|
|-
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|Disease
|
|
Line 1,247: Line 1,602:
|
|
|-
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|Disease
|
|
Line 1,258: Line 1,613:
|
|
|-
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|Disease
|
|
Line 1,269: Line 1,624:
|
|
|-
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Katie Schieffer
|9/21/2025
|12/31/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|
|
Line 1,280: Line 1,646:
|
|
|-
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,291: Line 1,666:
|
|
|-
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,302: Line 1,677:
|
|
|-
|-
|[[STBT5:PEComa|PEComa]]
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,313: Line 1,688:
|
|
|-
|-
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,324: Line 1,699:
|
|
|-
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,335: Line 1,710:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|[[STBT5:Osteoma|Osteoma]]
|Disease
|Disease
|Sadeem Qdaisat
|10/1/23
|
|
|PENDING
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|-
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Ganesh Pandurang, MD
|2/28/24
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|Disease
|
|
Line 1,400: Line 1,754:
|
|
|-
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
----
|
|
----
|
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Disease
|Fang Fang (trainee); Katie Schieffer (mentor)
|11/19/2025
|2/15/2026
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,443: Line 1,796:
|
|
|-
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,454: Line 1,807:
|
|
|-
|-
|[[STBT5:Enchondroma|Enchondroma]]
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|Disease
|
|
Line 1,465: Line 1,818:
|
|
|-
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|Disease
|
|
Line 1,476: Line 1,829:
|
|
|-
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|Disease
|
|
Line 1,487: Line 1,840:
|
|
|-
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,498: Line 1,851:
|
|
|-
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|Disease
|
|
Line 1,509: Line 1,873:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|Disease
|
|
Line 1,520: Line 1,884:
|
|
|-
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,531: Line 1,904:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|Disease
|
|
Line 1,542: Line 1,915:
|
|
|-
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|Disease
|
|
Line 1,553: Line 1,926:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|Disease
|
|
Line 1,564: Line 1,937:
|
|
|-
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|Disease
|
|
Line 1,575: Line 1,948:
|
|
|-
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|Disease
|
|
Line 1,586: Line 1,959:
|
|
|-
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association, early genetic studies referenced
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|Disease
|
|
Line 1,597: Line 1,981:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/22/2025
|Katie Schieffer
|10/22/2025
|
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|Disease
|
|
Line 1,619: Line 2,023:
|
|
|-
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|Disease
|
|
Line 1,630: Line 2,056:
|
|
|-
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|Refer to lipoma and hibernoma pages in STBT book
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Refer to leiomyosarcoma page in STBT book
|
|-
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|Disease
|
|
Line 1,652: Line 2,089:
|
|
|-
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|PENDING
|
|
|
|
|
|
|
|Refer to plasmacytoma page in heme book
|
|
|
|-
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|Disease
|
|
Line 1,958: Line 2,120:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''!!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
|
!'''Notes'''
|
|
|
|-
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
Line 1,991: Line 2,140:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
Line 2,002: Line 2,151:
|
|
|
|
|
|Refer to heme book
|-
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
Line 2,013: Line 2,162:
|
|
|
|
|
|Refer to heme book
|-
|-
|
|

Latest revision as of 08:31, 20 January 2026

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Atypical lipomatous tumour / well-differentiated liposarcoma Disease
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 Minimal genetic content added
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/16/2025 Katie Schieffer 10/16/2025 No genetic association
Elastofibroma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 9/22/2025 Katie Schieffer 9/22/2025 No genetic association
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/16/2025 Katie Schieffer 10/16/2025 No genetic association
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 No genetic association
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease Kati

e Schieffer

9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 Minimal genetic content added
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Solitary fibrous tumour Disease Yiting Li (trainee);

Shashirekha Shetty (mentor)

9/24/2025 12/24/2025 COMPLETE 12/18/2025 Katie Schieffer 12/18/2025
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

3/1/2026 6/30/2026 PENDING
Infantile fibrosarcoma Disease Katie Schieffer 4/21/2025 10/1/2025 COMPLETE 9/18/2025 Katie Schieffer 9/18/2025
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 No genetic association
Giant cell tumour of soft tissue Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Synovial haemangioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/10/2025 Katie Schieffer 11/10/2025 No genetic association
Intramuscular angioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 Minimal genetic content added
Papillary intralymphatic angioendothelioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 Minimal genetic content added
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 No genetic association
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Solitary circumscribed neuroma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 No genetic association
Ectopic meningioma and meningothelial hamartoma Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING Consider linking to CNS tumor book
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

9/11/2025 12/11/2025 COMPLETE 12/29/2026 Katie Schieffer 1/7/2026
Haemosiderotic fibrolipomatous tumour Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

3/1/2026 6/30/2026 PENDING
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 12/9/2025 PENDING Katie Schieffer
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease Maxine Sutcliffe, PhD 10/13/2025 12/31/2025 COMPLETE 12/24/2025 Katie Schieffer 12/24/2025
Clear cell sarcoma of soft tissue Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease Maxine Sutcliffe, PhD 1/12/2026 4/12/2026 PENDING
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease

CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
Ewing sarcoma Disease Sadeem Qdaisat (trainee); Eric McGinnis (mentor) 10/1/2023 12/9/2025 PENDING Katie Schieffer
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease
Sarcoma with BCOR genetic alterations Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 4 (BONE TUMOURS)
Subungual exostosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Bizarre parosteal osteochondromatous proliferation Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025
Periosteal chondroma Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING
Enchondroma Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING
Osteochondroma Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING
Chondroblastoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease Katie Schieffer 9/21/2025 12/31/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Osteosarcoma Disease Fang Fang (trainee); Katie Schieffer (mentor) 11/19/2025 2/15/2026 PENDING Katie Schieffer
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association
Epithelioid haemangioma of bone Disease
Epithelioid haemangioendothelioma of bone Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiosarcoma of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association, early genetic studies referenced
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association
Osteofibrous dysplasia Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/22/2025 Katie Schieffer 10/22/2025
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Adamantinoma of long bones Disease
Simple bone cyst Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Fibrocartilaginous mesenchymoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING Refer to lipoma and hibernoma pages in STBT book
Leiomyosarcoma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING Refer to leiomyosarcoma page in STBT book
Undifferentiated pleomorphic sarcoma Disease
Bone metastases Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Solitary plasmacytoma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 PENDING Refer to plasmacytoma page in heme book
Primary non-Hodgkin lymphoma of bone Disease Refer to heme book
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease Refer to heme book
Erdheim-Chester disease Disease Refer to heme book
Rosai-Dorfman disease Disease Refer to heme book

CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
Enchondromatosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
McCune-Albright syndrome Disease
Multiple osteochondromas Disease
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Rothmund-Thomson syndrome Disease
Werner syndrome Disease


Retrieved from "https://test.ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=20107"